LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 196 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,168 | -0.7% | 153 | +19.5% | 0.00% | – |
| Q2 2023 | $9,229 | +0.4% | 128 | +2.4% | 0.00% | – |
| Q1 2023 | $9,195 | +88.6% | 125 | +71.2% | 0.00% | – |
| Q4 2022 | $4,876 | +21.9% | 73 | +78.0% | 0.00% | – |
| Q3 2022 | $4,000 | -33.3% | 41 | -39.7% | 0.00% | – |
| Q2 2022 | $6,000 | 0.0% | 68 | +36.0% | 0.00% | – |
| Q1 2022 | $6,000 | -99.2% | 50 | -99.0% | 0.00% | -100.0% |
| Q4 2021 | $759,000 | +6225.0% | 4,911 | +5544.8% | 0.00% | – |
| Q3 2021 | $12,000 | -61.3% | 87 | -63.0% | 0.00% | – |
| Q2 2021 | $31,000 | -29.5% | 235 | -19.2% | 0.00% | – |
| Q1 2021 | $44,000 | -20.0% | 291 | -47.6% | 0.00% | – |
| Q4 2020 | $55,000 | -83.2% | 555 | -83.8% | 0.00% | -100.0% |
| Q3 2020 | $327,000 | -37.4% | 3,435 | -26.4% | 0.00% | -33.3% |
| Q2 2020 | $522,000 | +61.1% | 4,669 | +4.8% | 0.00% | +50.0% |
| Q1 2020 | $324,000 | -23.4% | 4,457 | +9.9% | 0.00% | 0.0% |
| Q4 2019 | $423,000 | +1.0% | 4,056 | -3.5% | 0.00% | -33.3% |
| Q3 2019 | $419,000 | +1.2% | 4,205 | +16.0% | 0.00% | 0.0% |
| Q2 2019 | $414,000 | -1.7% | 3,625 | +8.2% | 0.00% | 0.0% |
| Q1 2019 | $421,000 | -2.8% | 3,349 | +5.0% | 0.00% | 0.0% |
| Q4 2018 | $433,000 | -34.4% | 3,190 | +32.8% | 0.00% | -25.0% |
| Q3 2018 | $660,000 | +4.8% | 2,403 | -20.9% | 0.00% | 0.0% |
| Q2 2018 | $630,000 | +0.5% | 3,039 | -19.9% | 0.00% | 0.0% |
| Q1 2018 | $627,000 | -4.9% | 3,796 | -21.1% | 0.00% | 0.0% |
| Q4 2017 | $659,000 | +6.6% | 4,812 | +6.0% | 0.00% | 0.0% |
| Q3 2017 | $618,000 | -0.2% | 4,538 | -11.0% | 0.00% | -20.0% |
| Q2 2017 | $619,000 | +16.4% | 5,097 | +1.3% | 0.01% | +25.0% |
| Q1 2017 | $532,000 | -4.0% | 5,030 | -7.8% | 0.00% | 0.0% |
| Q4 2016 | $554,000 | -1.1% | 5,454 | -0.6% | 0.00% | -20.0% |
| Q3 2016 | $560,000 | -17.3% | 5,489 | -3.3% | 0.01% | -16.7% |
| Q2 2016 | $677,000 | -4.2% | 5,679 | -14.0% | 0.01% | 0.0% |
| Q1 2016 | $707,000 | -1.3% | 6,601 | -0.1% | 0.01% | 0.0% |
| Q4 2015 | $716,000 | +18.5% | 6,608 | -6.3% | 0.01% | 0.0% |
| Q3 2015 | $604,000 | -6.2% | 7,054 | +10.5% | 0.01% | 0.0% |
| Q2 2015 | $644,000 | -8.4% | 6,386 | -30.0% | 0.01% | 0.0% |
| Q1 2015 | $703,000 | +62.0% | 9,122 | +11.9% | 0.01% | +50.0% |
| Q4 2014 | $434,000 | +60.7% | 8,155 | +41.8% | 0.00% | +100.0% |
| Q3 2014 | $270,000 | -28.4% | 5,750 | -5.0% | 0.00% | -33.3% |
| Q2 2014 | $377,000 | +190.0% | 6,052 | +213.6% | 0.00% | +200.0% |
| Q1 2014 | $130,000 | – | 1,930 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |